Table 1 Change of CEA value at 12 and 18 weeks after the initiation of chemotherapy compared with clinical response according to RECIST criteria
From: The dynamic monitoring of CEA in response to chemotherapy and prognosis of mCRC patients
Clinical response according to RECIST criteria | |||
|---|---|---|---|
CR + PR + shrunken SD (tumor size decreased) | Enlarged SD (tumor size increased) + PD | Total | |
CEA change from baseline to 12 weeks | |||
Decreased≥50% | 19 | 13 | 32 (45.7%) |
Increased or decreased < 50% | 10 | 28 | 38 (54.3%) |
Total | 29 (41.4%) | 41 (58.6%) | 70 (100%) |
CEA change from 12 weeks to 18 weeks | |||
Decreased | 14 | 8 | 22 (27.9%) |
Increased | 8 | 14 | 22 (72.1%) |
Total | 22 (46.5%) | 22 (53.5%) | 44 (100%) |